These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2117320)

  • 1. [The effect of the protective antigen of Bacillus anthracis on the formation of immunity under the action of live anthrax vaccines].
    Abalakin VA; Buravtseva NP; Cherkasskiĭ BL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):72-5. PubMed ID: 2117320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
    Ivins BE; Welkos SL; Knudson GB; Little SF
    Infect Immun; 1990 Feb; 58(2):303-8. PubMed ID: 2105269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The assessment of antitoxic anti-anthrax immunity].
    Abalakin VA; Buravtseva NP; Neliapin NM
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):78-82. PubMed ID: 2129149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Aug; 5(2):127-39. PubMed ID: 3148815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.
    Ivins BE; Welkos SL; Little SF; Crumrine MH; Nelson GO
    Infect Immun; 1992 Feb; 60(2):662-8. PubMed ID: 1730501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity induced by Bacillus anthracis toxin-deficient strains.
    Pezard C; Weber M; Sirard JC; Berche P; Mock M
    Infect Immun; 1995 Apr; 63(4):1369-72. PubMed ID: 7890396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
    Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
    FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis.
    Singh Y; Ivins BE; Leppla SH
    Infect Immun; 1998 Jul; 66(7):3447-8. PubMed ID: 9632621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs.
    Little SF; Ivins BE; Fellows PF; Friedlander AM
    Infect Immun; 1997 Dec; 65(12):5171-5. PubMed ID: 9393812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.
    Cote CK; Kaatz L; Reinhardt J; Bozue J; Tobery SA; Bassett AD; Sanz P; Darnell SC; Alem F; O'Brien AD; Welkos SL
    J Med Microbiol; 2012 Oct; 61(Pt 10):1380-1392. PubMed ID: 22767539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
    Little SF; Knudson GB
    Infect Immun; 1986 May; 52(2):509-12. PubMed ID: 3084385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
    Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Broster MG; Carman JA; Manchee RJ; Melling J
    Infect Immun; 1986 May; 52(2):356-63. PubMed ID: 3084381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen.
    Barnard JP; Friedlander AM
    Infect Immun; 1999 Feb; 67(2):562-7. PubMed ID: 9916059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
    Shakya KP; Hugh-Jones ME; Elzer PH
    Vaccine; 2007 Jul; 25(29):5374-7. PubMed ID: 17555849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.
    Iacono-Connors LC; Welkos SL; Ivins BE; Dalrymple JM
    Infect Immun; 1991 Jun; 59(6):1961-5. PubMed ID: 1903769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.